Keywords: uk, ok, femara, early, breast, cancer, medicines

UK OK for Femara in early breast cancer

Article | 12 December 2005

Print This

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of Swiss drug major Novartis' aromatase inhibitor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in